477 related articles for article (PubMed ID: 9934864)
21. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine.
Kim DJ; Han BS; Ahn B; Lee KK; Kang JS; Tsuda H
Cancer Lett; 1996 Jun; 104(1):13-9. PubMed ID: 8640739
[TBL] [Abstract][Full Text] [Related]
22. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism.
Gradelet S; Le Bon AM; Bergès R; Suschetet M; Astorg P
Carcinogenesis; 1998 Mar; 19(3):403-11. PubMed ID: 9525273
[TBL] [Abstract][Full Text] [Related]
23. Presence of a no-observed effect level for enhancing effects of development of the alpha-isomer of benzene hexachloride (alpha-BHC) on diethylnitrosamine-initiated hepatic foci in rats.
Masuda C; Wanibuchi H; Otori K; Wei M; Yamamoto S; Hiroi T; Imaoka S; Funae Y; Fukushima S
Cancer Lett; 2001 Feb; 163(2):179-85. PubMed ID: 11165752
[TBL] [Abstract][Full Text] [Related]
24. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
[TBL] [Abstract][Full Text] [Related]
25. Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.
Wang L; He L; Zeng H; Fu W; Wang J; Tan Y; Zheng C; Qiu Z; Luo J; Lv C; Huang Y; Shu W
Chemosphere; 2020 Jun; 248():126036. PubMed ID: 32045972
[TBL] [Abstract][Full Text] [Related]
26. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
Ito S; Tateno C; Tuda M; Yoshitake A
Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
[TBL] [Abstract][Full Text] [Related]
28. Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker.
Ito N; Tatematsu M; Hasegawa R; Tsuda H
Toxicol Pathol; 1989; 17(4 Pt 1):630-41. PubMed ID: 2629099
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.
Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD
Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of nongenotoxic and genotoxic carcinogens on the preneoplastic lesions in the rat liver.
Kim DJ; Lee KK; Hong JT
Arch Pharm Res; 1998 Aug; 21(4):363-9. PubMed ID: 9875460
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice.
Lian M; Liu Y; Yu SZ; Qian GS; Wan SG; Dixon KR
World J Gastroenterol; 2006 May; 12(19):3065-72. PubMed ID: 16718789
[TBL] [Abstract][Full Text] [Related]
32. Species and sex differences of aflatoxin B1-induced glutathione S-transferase placental form in single hepatocytes.
Tsuji K; Gopalan P; Lehmann K; Kimura M; Horiuchi A; Sato K; Lotlikar PD
Cancer Lett; 1992 Oct; 66(3):249-54. PubMed ID: 1451106
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of GST-P positive liver cell foci development by a medium-term carcinogenicity bioassay using repeated administration of D-galactosamine.
Kim HC; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1995 Nov; 98(1):71-6. PubMed ID: 8529208
[TBL] [Abstract][Full Text] [Related]
34. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR.
Nishiwaki-Matsushima R; Ohta T; Nishiwaki S; Suganuma M; Kohyama K; Ishikawa T; Carmichael WW; Fujiki H
J Cancer Res Clin Oncol; 1992; 118(6):420-4. PubMed ID: 1618889
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of preneoplastic lesion yield by Chios Mastic Gum in a rat liver medium-term carcinogenesis bioassay.
Doi K; Wei M; Kitano M; Uematsu N; Inoue M; Wanibuchi H
Toxicol Appl Pharmacol; 2009 Jan; 234(1):135-42. PubMed ID: 18977376
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure.
Imaida K; Hagiwara A; Yoshino H; Tamano S; Sano M; Futakuchi M; Ogawa K; Asamoto M; Shirai T
Cancer Lett; 2000 Jul; 155(1):105-14. PubMed ID: 10814886
[TBL] [Abstract][Full Text] [Related]
38. Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
Johnson NM; Egner PA; Baxter VK; Sporn MB; Wible RS; Sutter TR; Groopman JD; Kensler TW; Roebuck BD
Cancer Prev Res (Phila); 2014 Jul; 7(7):658-65. PubMed ID: 24662598
[TBL] [Abstract][Full Text] [Related]
39. Alterations in populations of GST-p-immunoreactive single hepatocytes and hepatocellular foci after a single injection of N-nitrosodiethylamine with or without phenobarbital promotion in male F344/NCr rats.
Jang JJ; Henneman JR; Kurata Y; Uno H; Ward JM
Cancer Lett; 1993 Jul; 71(1-3):89-95. PubMed ID: 8364903
[TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
